Gene Regulation and Thalassemia Study Notes
Learning Objectives
Recognize gene expression alterations in genetic diseases.
Predict various mechanisms that regulate gene expression.
Gene Regulation Techniques
Northern Blot Analysis
Purpose: Detect levels of mRNA, aiding the understanding of gene regulation.
Definition: Northern Blotting is a technique used to visualize specific RNA sequences, specifically mRNA.
Steps in Northern Blotting
Isolation of mRNAs:
mRNAs are extracted from the specific cells of interest and then run on a gel.
All mRNA present in the cell will be portrayed on the gel.
Transfer to Membrane:
The mRNAs from the gel are transferred onto a membrane utilizing capillary action.
Probe Hybridization:
The membrane is incubated with a labeled probe designed to bind specifically to the target mRNA.
The probe can be radioactively labeled or labeled with other methods for visualization.
Visualization:
The membrane is exposed to X-ray film, where the radioactive probe creates a dark spot representative of the bound mRNA.
Probe Information
Labeled Probe: Radioactively labeled DNA or RNA that hybridizes to complementary mRNA.
Unlabeled mRNA Sample: The sample without any label necessary for target visualization, analyzed comparing to labeled probe results.
Applications of Northern Blot Analysis
Used to determine if an mRNA is expressed in specific tissues.
Example: Measuring the expression of specific mRNA across various tissues such as muscle, liver, small intestine, brain, and white adipose tissue.
Close examination of band intensity (thickness) and location on gel provides information about the amount of mRNA present in a sample, though sequencing is required for exact sequences.
Comparison to Modern Techniques
RNA Sequencing (RNAseq):
A modern technique that allows high-throughput and unbiased transcriptome profiling.
Capable of revealing sequence, abundance, splice variants, and novel transcripts.
Can detect single-nucleotide variants and editing events.
Case Study: Hemoglobin and Thalassemia
Overview of Thalassemia
Thalassemia is characterized as a genetic blood disorder resulting from either inadequate levels or structural abnormalities of the alpha or beta subunits of hemoglobin.
Function of Hemoglobin: It binds to and transports oxygen from the lungs to various tissues via blood circulation.
Hemoglobin Protein Composition: A tetramer comprised of two alpha and two beta globin polypeptides.
Symptoms of Thalassemia
Common Symptoms:
Anemia
Weakness
Poor growth
Enlarged liver and spleen
Bone deformities
Treatment Options for Thalassemia
Blood Transfusion: Management of anemia and blood level requirements.
Iron Chelation Therapy: Treatment to reduce iron buildup from repeated transfusions.
Cures:
Stem cell transplantation.
Gene therapy as a potentially curative option.
Activity Section: Analyze Northern Blot Results
Activity Questions
Conduct analysis for patients 1-3 on Northern blot results and propose
a. A potential mutation location and type which could lead to observed results.
b. Proposed mutation types for patient 4, possibly leading to their results.
c. For patient 5:
i. If patient 5 has normal β globin mRNA levels but a non-functional protein, propose likely mutation type.
ii. If patient 5 has reduced amounts of β globin protein, propose likely mutation type.
iii. If patient 5 shows normal mRNA expression yet decreasing protein, analyze potential mutation type causing rapid degradation.
Question Analysis Activities
Propose mutations related to patient analyses leading to β thalassemia in case study patient 4:
A) Nonsense mutation
B) Frameshift mutation
C) Missense mutation
D) Mutation creating an alternate splice site
Mutation Impact Question
Identify the likely mutation causing rapid protein degradation:
A) A stop codon
B) A mutation in the 5’ UTR
C) A mutation in the 3’ UTR
D) A missense mutation resulting in a misfolded protein